Humacyte's market cap is currently $482.51M. The company's EPS TTM is $-1.34; its P/E ratio is ―; Humacyte is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 1.56M	$ 1.26M	$ 1.49M	$ 6.19M
Gross Profit	$ -76.55M	$ -6.69M	$ 1.21M	$ -6.94M	$ -69.42M
Operating Income	$ -100.05M	$ -84.58M	$ -81.21M	$ -64.60M	$ -85.69M
EBITDA	$ -96.46M	$ 2.49M	$ -72.97M	$ -56.25M	$ -78.94M
Net Income	$ -110.78M	$ 64.22M	$ 37.54M	$ -68.73M	$ -85.42M
Balance Sheet
Cash & Short-Term Investments	$ 80.45M	$ 151.88M	$ 225.50M	$ 39.93M	$ 93.71M
Total Assets	$ 128.22M	$ 204.30M	$ 286.53M	$ 106.69M	$ 168.69M
Total Debt	$ 57.51M	$ 47.76M	$ 48.47M	$ 28.86M	$ 25.65M
Net Debt	$ -22.94M	$ -102.01M	$ -169.03M	$ -11.07M	$ -68.06M
Total Liabilities	$ 114.68M	$ 87.37M	$ 164.36M	$ 457.00M	$ 36.49M
Stockholders' Equity	$ 13.55M	$ 116.93M	$ 122.17M	$ -350.32M	$ 132.20M
Cash Flow
Free Cash Flow	$ -75.58M	$ -72.18M	$ -81.41M	$ -55.89M	$ -79.91M
Operating Cash Flow	$ -73.31M	$ -71.13M	$ -81.19M	$ -55.57M	$ -71.79M
Investing Cash Flow	$ -173.00K	$ 4.84M	$ -8.22M	$ -268.00K	$ -8.13M
Financing Cash Flow	$ 4.51M	$ -1.45M	$ 266.98M	$ 2.05M	$ -74.00K

Currency in USD

Humacyte Earnings and Revenue History

Income Statement >

Humacyte Debt to Assets

Balance Sheet >

Humacyte Cash Flow

Cash Flow >

Humacyte Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing